The global enzymes market is estimated to be valued at USD 14.0 billion in 2024 and is projected to reach USD 20.4 billion by 2029, recording a CAGR of 7.8%. The growth of the enzymes market is fueled by key factors such as a notable surge in demand for processed foods, driven by changing consumer lifestyles and preferences. This trend necessitates the use of enzymes to improve the quality, texture, and shelf life of these products. Enzymes find expanding applications across various industries, including pharmaceuticals, biofuels, textiles, and more, contributing to their widespread adoption and market growth. The expanding business has offered lucrative business opportunities to the players who are operating in the market segments. For instance, in June 2023, Kerry Group plc. Introduces Biobake EgR, an innovative enzyme solution that reduces egg usage in various baking applications, allowing European manufacturers to switch to free-range or organic eggs without increasing costs. Other major players, such as Dyadic International, Inc. (US), Dyadic International entered a development and exclusive license agreement to commercialize non-animal dairy enzymes with Dapibus, receiving a USD 0.6 million upfront payment in October 2023. The company achieved the target yield for a milestone payment, pending partner verification, and is progressing well with developing a second enzyme. This boosts Dyadic's market position.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46202020
The specialty enzymes segment is projected to hold a significant market share in the enzymes market during the forecast period.
Specialty enzymes play a critical role in the pharmaceutical and biotechnology industries. These enzymes are essential in biopharmaceutical production, including monoclonal antibodies and gene therapies, where precision and specificity are paramount. For instance, the enzyme proteinase K is widely used in DNA and RNA extraction processes for genomic research, which has seen increased demand due to advancements in personalized medicine and diagnostics. The specialty enzymes segment benefits from significant R&D investments and innovations. Companies like Novozymes A/S (Denmark) and DSM-Firmenich (Switzerland) are focusing on developing novel enzymes with improved stability and activity for specific industrial applications. For example, in May 2023, DSM-Firmenich launched Maxilact Next speeds milk processing by 25%, optimizing lactose-free dairy production and efficiency without altering taste. Furthermore, regulatory support for biopharmaceuticals and the increasing prevalence of chronic diseases requiring advanced treatments contribute to the growth of specialty enzymes, solidifying their market dominance.
The plant-derived enzymes segment holds a significant market share in the enzymes market.
The use of amylase derived from barley and wheat in the brewing industry. Amylase is critical for breaking down starches into fermentable sugars, which improves the efficiency and quality of beer production. Additionally, pectinase, sourced from fruits like apples and oranges, is extensively used in the juice and wine industries to clarify beverages and increase juice yield. Plant enzymes also play a crucial role in the growing market for plant-based and vegan products. For instance, transglutaminase, derived from plant sources, is utilized in meat alternatives to improve texture and binding properties, addressing the increasing consumer demand for sustainable and ethical food options. This trend is supported by the rising popularity of plant-based diets, which boosts the market for plant-derived enzymes. Moreover, companies like Novozymes have invested significantly in developing plant-based enzyme solutions tailored to specific industry needs. In March 2020, Novozymes A/S (Denmark) introduced Saphera Fiber, a lactase enzyme derived from plants, designed to increase fiber content in dairy products while reducing sugar levels, catering to health-conscious consumers. The market growth is also driven by advancements in enzyme extraction and formulation technologies, which enhance enzyme stability and functionality. The scalability of plant enzyme production, combined with regulatory support for natural and non-GMO ingredients, further solidifies the plant segment's substantial market share in the enzyme industry.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46202020
Asia Pacific Region Holds the Largest Share of the Enzymes Market
The region's food and beverage sector is rapidly expanding due to rising consumer demand for processed foods and beverages. For example, the demand for convenience foods and beverages in countries like China and India is soaring, driving the need for food-processing enzymes. According to Nestlé India Annual Report, 2023, Nestlé has committed to investing USD 700 million in expanding its manufacturing capabilities to meet the rising consumer demand for processed foods.
Key players in this market include BASF SE (Germany), International Flavors & Fragrances Inc. (US), DSM-Firmenich (Switzerland), Associated British Foods plc (England), Novozymes A/S (Denmark), Kerry Group plc. (Ireland), Dyadic International Inc. (US), Advanced Enzyme Technologies (India), Aumgene Biosciences (India), Amano Enzyme Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Adisseo (China).
